Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO
“On behalf of the entire board, I want to thank John for his leadership and dedication to Ingevity over the past nine years,” said Jean Blackwell, chair of the board of directors. “Under John’s guidance, Ingevity successfully transitioned into a standalone public company, expanded its global footprint and established itself as a leader in key markets. We are grateful for his contributions and wish him the very best in his future endeavors.”
“I thank the board for letting me serve Ingevity for these years, and I wish Ingevity the best going forward,” said John Fortson.
“Ingevity has made significant progress in recent years, successfully navigating a period of strategic transformation and portfolio optimization,” said Fernandez-Moreno. “I, too, thank John for his service and firmly believe that Ingevity is well-positioned for long-term success thanks to his leadership. I am eager to work alongside our talented and committed team to build upon our progress thus far and focus on successfully executing the company’s plans to improve business performance.”
Fernandez-Moreno has been a member of Ingevity’s board of directors since its spinoff in 2016. He was chair of the nominating and governance committee, a position he resigned to assume the role of interim president and CEO.
Fernandez-Moreno has a 40-year history of successfully leading complex global businesses in the specialty chemicals industry, including as president of Ashland Inc.’s Chemicals division, a
The board has initiated a search process to identify a permanent president and CEO and has retained a leading executive search firm to assist in the process.
Ingevity plans to release its third quarter 2024 earnings after the stock market close on Wednesday, October 30, 2024, and hold a live webcast on Thursday, October 31, to discuss third quarter 2024 fiscal results.
Ingevity: Purify, Protect and Enhance
Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words “will,” “plans,” “intends,” “targets,” “expects,” “outlook,” “believes,” “anticipates” or similar expressions. Forward-looking statements may include, without limitation, leadership transitions; expected financial positions, guidance, results of operations and cash flows; financing plans; and business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our most recent Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management’s beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241003721926/en/
Caroline Monahan
843-740-2068
caroline.monahan@ingevity.com
Investors:
John E. Nypaver, Jr.
843-740-2002
investors@ingevity.com
Source: Ingevity Corporation